News

LM Funding America, Inc. Unveils Third Quarter 2024 Results

LM Funding America, Inc. Unveils Third Quarter 2024 Results

LM Funding America, Inc. Reports Third Quarter Financial Results

LM Funding America, Inc. (NASDAQ: LMFA), a company specializing in cryptocurrency mining and technology-based financing, has released its financial updates and business strategy insights for the third quarter.

Key Financial Highlights

As of September 30, the company holds 142.3 Bitcoin valued at approximately $12.4 million, aligning with recent Bitcoin prices. The cost efficiency in mining has improved significantly compared to last year.

CEO's Vision

CEO Bruce Rodgers expressed optimism towards Bitcoin's market trajectory, focusing on a vertically integrated strategy for enhanced operations and profitability. With Bitcoin's recent surge surpassing $87,000, LM Funding is poised for robust growth as it eyes a target above $100,000 by 2025.

Strategic Developments to Enhance Growth

Post the halving event in April, the company pivoted towards a more integrated business model, emphasizing low-cost power and market expansion. This strategic alignment is set to secure sustainable operational practices that will bolster revenues.

Leadership Transition

With Ryan Duran now at the helm as President of US Digital Mining and Hosting Co LLC, the strategic approach will focus on maximizing operational efficiency while discovering new cost-effective mining sites.

Operational Performance Overview

During Q3 2024, LM Funding successfully mined 18.5 Bitcoin, generating around $1.1 million in revenue despite a market dip in mined volumes. The overall revenue for Q3 stood at approximately $1.3 million, down from previous yearly figures, primarily due to the market adjustments following the halving event.

Quarterly Financial Performance

The digital mining revenue witnessed a decline from $3.3 million to $1.1 million, reflecting the challenges posed by the reduced volume mined as a result of the halving and transitions in operational venues. Operating expenses also saw a slight decline to $5.7 million, indicating effective cost management amidst market volatility.

Core EBITDA Explained

Core EBITDA loss for the quarter was reported at $1.6 million, with an overall positive trend in the nine-month figure, highlighting the benefits of expanded Bitcoin operations and operational resilience.

Future Outlook

CFO Richard Russell remarked on the company’s strong position with approximately $14.9 million in cash and cryptocurrency assets. The confidence in Bitcoin’s long-term appreciation drives the company’s strategic choices moving forward, cementing its place in the volatile digital financial landscape.

Investor Call Insights

For interested stakeholders, LM Funding has scheduled an investor conference call to delve deeper into the quarterly results and share broader insights into its corporate trajectory.

About LM Funding America

Established in 2022, LM Funding America, Inc., and its subsidiaries operate at the intersection of cryptocurrency and financing, focusing primarily on supporting non-profit community associations through innovative revenue strategies and funding programs.

Frequently Asked Questions

What are the key financial highlights for Q3 2024 for LMFA?

LMFA reported holding 142.3 Bitcoins, translating to a value of approximately $12.4 million, amidst notable operations improvements.

What strategic plans does LMFA have for the future?

LMFA aims to focus on a vertically integrated operational strategy, targeting low-cost power sources to enhance profitability.

How did the halving event impact LMFA's revenue?

The halving led to a decreased mined volume, which significantly affected revenue, resulting in a drop from $3.3 million to $1.1 million in digital mining revenue.

Who has been appointed as the President of US Digital Mining?

Ryan Duran has been named President, overseeing the strategic direction of the company's digital mining operations.

What is the current financial outlook for Bitcoin?

The company maintains a positive outlook, speculating a rise above $100,000 by 2025, supported by recent price surges.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 1

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 3

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 2

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 2

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 7

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading

Top 5 Most Recently Viewed Articles

NanoXplore Gains Government Support for Innovative Battery Tech

Updated Category News Views 193

NanoXplore Secures Government Funding for Battery Innovation In a significant development for the battery technology sector, NanoXplore Inc. (TSX: GRA and OTCQX: NNXPF), a frontrunner in graphene production, recently announced a contribution of up to $2.75 million from the Canadian government as part of the Energy Innovation Program (EIP). This contribution is expected to...

Continue Reading
Equinor ASA Declares Cash Dividend for First Quarter 2025

Updated Category News Views 272

Equinor ASA Announces an Exciting Cash Dividend Equinor ASA (OSE: EQNR, NYSE: EQNR) has made an important announcement regarding its dividend strategy for shareholders. As part of its ongoing commitment to deliver value, the company has declared a cash dividend of NOK 3.7740 per share for the first quarter of 2025. Understanding the Dividend Amount The cash dividend of...

Continue Reading
RIAS A/S Shares Insights from Recent Half-Year Performance

Updated Category News Views 469

Analyzing the Half-Year Performance of RIAS A/S RIAS A/S has recently released its half-year report, offering a clear view into the company's operational status and financial health. This report is crucial for stakeholders and potential investors to understand how RIAS A/S is navigating through the current economic landscape. Key Financial Highlights In this reporting...

Continue Reading
Starbucks Stock Analysis: Opportunities and Challenges Ahead

Updated Category News Views 156

Understanding Starbucks Stock Performance Starbucks Corporation's stock, trading under the ticker SBUX, is currently observed at a forward 12-month Price/Earnings ratio of 24.79x. This figure places it just slightly below the Zacks Restaurant industry average of 24.97x. However, it's noteworthy that SBUX's valuation exceeds the broader Retail-Wholesale sector, which has a...

Continue Reading
Explore Innovations at the 2024 GenScript Biotech Forum

Updated Category News Views 314

Join Experts at the 2024 GenScript Biotech Global Forum The year ahead is shaping up to be crucial for Cell and Gene Therapy (CGT), and the "2024 GenScript Biotech Global Forum" offers an ideal setting for essential discussions. Top experts will gather to exchange insights on groundbreaking therapies such as Amtagvi and PM359, which promise new opportunities in treatment....

Continue Reading